United States · Bill · HR
H.R. 7265 (117th)
Cerebral Palsy Research Program Authorization Act of 2022
Introduced
29 March 2022
Last action
—
Status
Referred to the Subcommittee on Health.
Sponsors
—
Subjects
Discovery layer
Source updated
3 January 2025
Summary
Cerebral Palsy Research Program Authorization Act of 2022 This bill expands research activities related to cerebral palsy (a group of disorders caused by abnormal brain development or damage that affects an individual's ability to move and maintain balance and posture). Specifically, the Centers for Disease Control and Prevention must carry out a cerebral palsy research program that addresses diagnosis and treatment, public health surveillance, and related matters. Additionally, the National Institute of Neurological Disorders and Stroke and the Eunice Kennedy Shriver National Institute of Child Health and Human Development must update an existing strategic plan for cerebral palsy research.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 29 March 2022
Introduced in House (PDF)
Introduced in House · EN · 29 March 2022
Introduced in House
summary · EN · 29 March 2022
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/house-bill/7265
- Open data entity: https://api.congress.gov/v3/bill/117/hr/7265